PIM kinases are progression markers and emerging therapeutic targets in diffuse large B-cell lymphoma

por Brault, L, Menter, T, Obermann, E C, Knapp, S, Thommen, S, Schwaller, J, Tzankov, A
Publicado 2012

Mcm2 predicts recurrence hazard in stage Ta/T1 bladder cancer more accurately than CK20, Ki67 and histological grade

por Burger, M, Denzinger, S, Hartmann, A, Wieland, W-F, Stoehr, R, Obermann, E C
Publicado 2007

EpCAM expression varies significantly and is differentially associated with prognosis in the luminal B HER2(+), basal-like, and HER2 intrinsic subtypes of breast cancer

por Soysal, S D, Muenst, S, Barbie, T, Fleming, T, Gao, F, Spizzo, G, Oertli, D, Viehl, C T, Obermann, E C, Gillanders, W E
Publicado 2013

Nuclear Expression of Snail Is an Independent Negative Prognostic Factor in Human Breast Cancer

por Muenst, S., Däster, S., Obermann, E. C., Droeser, R. A., Weber, W. P., von Holzen, U., Gao, F., Viehl, C., Oertli, D., Soysal, S. D.
Publicado 2013